105 Comac St.
Ronkonkoma
NY
11779
USA
631-676-2730
Product Categories
Related Content
November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...
November 20, 2023
November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first ...
November 15, 2023
January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment ...
January 09, 2023
September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the ...
September 26, 2022
Feature | Hypertension| By Dave Fornell, Editor
May 16, 2021 — Two months after undergoing renal denervation (RDN) with the ReCor Paradise renal denervation system ...
May 16, 2021
May 31, 2018 – ReCor Medical announced that the RADIANCE-HTN SOLO study met its primary efficacy endpoint and ...
May 30, 2018
January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant ...
January 28, 2014
Feature | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat ...
July 30, 2013
April 11, 2012 — ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked ...
April 12, 2012
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for ...
February 20, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now